{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T02:39:15Z","timestamp":1792118355989,"version":"4.4.0"},"reference-count":68,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T00:00:00Z","timestamp":1673222400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Breast cancer treatment, such as chemotherapy and endocrine therapy, can cause earlier and more sudden menopausal symptoms. Genitourinary syndrome of menopause (GSM) is one of the most bothersome side effects of breast cancer treatment, resulting in sexual dysfunction and impaired quality of life. GSM includes genital, urinary, and sexual symptoms. However, alleviating symptoms of GSM for breast cancer survivors may be challenging due to ineffectiveness, contraindications, and low adherence to treatment. The most recent data show the feasibility and safety of vaginal laser to treat GSM for breast cancer survivors. This narrative review provides the aspects of GSM in breast cancer patients, putting the focus on the efficacy and safety of vaginal laser therapy.<\/jats:p>","DOI":"10.3390\/medicina59010132","type":"journal-article","created":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T01:30:47Z","timestamp":1673314247000},"page":"132","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Emerging Use of Vaginal Laser to Treat Genitourinary Syndrome of Menopause for Breast Cancer Survivors: A Review"],"prefix":"10.3390","volume":"59","author":[{"given":"Nida","family":"Jugulyt\u0117","sequence":"first","affiliation":[{"name":"Faculty of Medicine, Vilnius University, LT-03101 Vilnius, Lithuania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7844-4275","authenticated-orcid":false,"given":"Guoda","family":"\u017dukien\u0117","sequence":"additional","affiliation":[{"name":"Clinic of Obstetrics and Gynaecology, Faculty of Medicine, Institute of Clinical Medicine, Vilnius University, LT-03101 Vilnius, Lithuania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daiva","family":"Bartkevi\u010dien\u0117","sequence":"additional","affiliation":[{"name":"Clinic of Obstetrics and Gynaecology, Faculty of Medicine, Institute of Clinical Medicine, Vilnius University, LT-03101 Vilnius, Lithuania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,1,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"20211033","DOI":"10.1259\/bjr.20211033","article-title":"Understanding breast cancer as a global health concern","volume":"95","author":"Wilkinson","year":"2022","journal-title":"Br. J. Radiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21590","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J. Clin."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"71","DOI":"10.5306\/wjco.v13.i2.71","article-title":"Management of genitourinary syndrome of menopause in breast cancer survivors: An update","volume":"13","year":"2022","journal-title":"World J. Clin. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.maturitas.2016.06.010","article-title":"The REVIVE (REal Women\u2019s VIews of Treatment Options for Menopausal Vaginal ChangEs) survey in Europe: Country-specific comparisons of postmenopausal women\u2019s perceptions, experiences and needs","volume":"91","author":"Nappi","year":"2016","journal-title":"Maturitas"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/GME.0000000000001260","article-title":"Investigators on behalf of the ES. The burden of vulvovaginal atrophy on women\u2019s daily living: Implications on quality of life from a face-to-face real-life survey","volume":"26","author":"Nappi","year":"2019","journal-title":"Menopause"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"North American Menopause Society (2020). The 2020 genitourinary syndrome of menopause position statement of The North American Menopause Society. Menopause, 27, 976\u2013992.","DOI":"10.1097\/GME.0000000000001609"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1097\/GME.0000000000000329","article-title":"Genitourinary syndrome of menopause: New terminology for vulvovaginal atrophy from the International Society for the Study of Women\u2019s Sexual Health and The North American Menopause Society","volume":"21","author":"Portman","year":"2014","journal-title":"Menopause"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1097\/GRF.0000000000000126","article-title":"Vulvar and Vaginal Atrophy: Physiology, Clinical Presentation, and Treatment Considerations","volume":"58","year":"2015","journal-title":"Clin. Obstet. Gynecol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3389\/fmed.2018.00181","article-title":"The Vaginal Microenvironment: The Physiologic Role of Lactobacilli","volume":"5","author":"Amabebe","year":"2018","journal-title":"Front. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.ajog.2016.07.045","article-title":"Genitourinary syndrome of menopause: An overview of clinical manifestations, pathophysiology, etiology, evaluation, and management","volume":"215","author":"Gandhi","year":"2016","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1016\/j.anplas.2020.05.002","article-title":"Carbon dioxide laser treatment for vulvovaginal atrophy in women treated for breast cancer: Preliminary results of the feasibility EPIONE trial","volume":"65","author":"Hersant","year":"2020","journal-title":"Ann. Chir. Plast. Esth\u00e9tique"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/GME.0000000000001463","article-title":"Systemic estradiol levels with low-dose vaginal estrogens","volume":"27","author":"Santen","year":"2019","journal-title":"Menopause"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e2232563","DOI":"10.1001\/jamanetworkopen.2022.32563","article-title":"Comparison of Severity of Genitourinary Syndrome of Menopause Symptoms After Carbon Dioxide Laser vs Vaginal Estrogen Therapy: A Systematic Review and Meta-analysis","volume":"5","author":"Jang","year":"2022","journal-title":"JAMA Netw. Open"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1097\/GME.0000000000000672","article-title":"Fractional microablative CO2 laser for vulvovaginal atrophy in women treated with chemotherapy and\/or hormonal therapy for breast cancer: A retrospective study","volume":"23","author":"Pagano","year":"2016","journal-title":"Menopause"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s00404-016-4118-6","article-title":"Fractional CO2 laser for vulvovaginal atrophy (VVA) dyspareunia relief in breast cancer survivors","volume":"294","author":"Pieralli","year":"2016","journal-title":"Arch. Gynecol. Obstet."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/GME.0000000000000761","article-title":"Vaginal erbium laser as second-generation thermotherapy for the genitourinary syndrome of menopause: A pilot study in breast cancer survivors","volume":"24","author":"Gambacciani","year":"2017","journal-title":"Menopause"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1007\/s10103-018-2471-3","article-title":"Fractional CO2 laser for genitourinary syndrome of menopause in breast cancer survivors: Clinical, immunological, and microbiological aspects","volume":"33","author":"Becorpi","year":"2018","journal-title":"Lasers Med. Sci."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1007\/s00432-018-2614-8","article-title":"Ablative dual-phase Erbium:YAG laser treatment of atrophy-related vaginal symptoms in post-menopausal breast cancer survivors omitting hormonal treatment","volume":"144","author":"Mothes","year":"2018","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1097\/GME.0000000000001053","article-title":"Fractional microablative CO2 laser in breast cancer survivors affected by iatrogenic vulvovaginal atrophy after failure of nonestrogenic local treatments: A retrospective study","volume":"25","author":"Pagano","year":"2018","journal-title":"Menopause"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1097\/GME.0000000000001353","article-title":"The effect of vaginal erbium laser treatment on sexual function and vaginal health in women with a history of breast cancer and symptoms of the genitourinary syndrome of menopause: A prospective study","volume":"26","author":"Valadares","year":"2019","journal-title":"Menopause"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s10549-019-05384-9","article-title":"Vaginal CO2 laser for the treatment of vulvovaginal atrophy in women with breast cancer: LAAVA pilot study","volume":"178","author":"Pearson","year":"2019","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e539","DOI":"10.1016\/j.clbc.2021.01.006","article-title":"Microablative Fractional CO2 Laser for Vulvovaginal Atrophy in Women with a History of Breast Cancer: A Pilot Study at 4-week Follow-up","volume":"21","author":"Salvatore","year":"2021","journal-title":"Clin. Breast Cancer"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/tbj.14211","article-title":"Fractional CO\u2082 vaginal laser for the genitourinary syndrome of menopause in breast cancer survivors","volume":"27","author":"Siliquini","year":"2021","journal-title":"Breast J."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s10549-021-06226-3","article-title":"Effects of local laser treatment on vulvovaginal atrophy among women with breast cancer: A prospective study with long-term follow-up","volume":"188","author":"Veron","year":"2021","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Quick, A.M., Hundley, A., Evans, C., Stephens, J.A., Ramaswamy, B., Reinbolt, R.E., Noonan, A.M., Van Deusen, J.B., Wesolowski, R., and Stover, D.G. (2022). Long-Term Follow-Up of Fractional CO2 Laser Therapy for Genitourinary Syndrome of Menopause in Breast Cancer Survivors. J. Clin. Med., 11.","DOI":"10.3390\/jcm11030774"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1007\/s12282-021-01260-x","article-title":"Genitourinary symptoms in women with breast cancer: What do oncology health professionals think and do about them?","volume":"28","author":"Pearson","year":"2021","journal-title":"Breast Cancer"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.jsxm.2017.01.010","article-title":"The Women\u2019s EMPOWER Survey: Identifying Women\u2019s Perceptions on Vulvar and Vaginal Atrophy and Its Treatment","volume":"14","author":"Kingsberg","year":"2017","journal-title":"J. Sex. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"99","DOI":"10.4103\/jmh.jmh_93_21","article-title":"Genitourinary Syndrome of Menopause Assessment Tools","volume":"12","author":"Mension","year":"2021","journal-title":"J.-Life Health"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1080\/009262300278597","article-title":"The Female Sexual Function Index (FSFI): A multidimensional self-report instrument for the assessment of female sexual function","volume":"26","author":"Rosen","year":"2000","journal-title":"J. Sex. Marital Ther."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s10549-015-3499-8","article-title":"Development and validation of the Female Sexual Function Index adaptation for breast cancer patients (FSFI-BC)","volume":"152","author":"Bartula","year":"2015","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3389\/fendo.2019.00561","article-title":"Addressing Vulvovaginal Atrophy (VVA)\/Genitourinary Syndrome of Menopause (GSM) for Healthy Aging in Women","volume":"10","author":"Nappi","year":"2019","journal-title":"Front. Endocrinol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00192-014-2464-0","article-title":"Assessment of vaginal atrophy: A review","volume":"26","author":"Weber","year":"2015","journal-title":"Int. Urogynecology J."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/2211738507666190122111224","article-title":"Drug Combinations in Breast Cancer Therapy","volume":"7","author":"Fisusi","year":"2019","journal-title":"Pharm. Nanotechnol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s11864-017-0442-8","article-title":"Ovarian Function Suppression in Premenopausal Women with Early-Stage Breast Cancer","volume":"18","author":"Lambertini","year":"2017","journal-title":"Curr. Treat Options Oncol."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Kim, S., Kim, S.W., Han, S.J., Lee, S., Park, H.T., Song, J.Y., and Kim, T. (2021). Molecular Mechanism and Prevention Strategy of Chemotherapy- and Radiotherapy-Induced Ovarian Damage. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22147484"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.bpobgyn.2018.07.008","article-title":"Ovarian effects of radiation and cytotoxic chemotherapy damage","volume":"55","author":"Cosgrove","year":"2019","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.2217\/fon.14.110","article-title":"Estrogen and progesterone receptors in breast cancer","volume":"10","author":"Yip","year":"2014","journal-title":"Future Oncol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1016\/S0140-6736(20)32381-3","article-title":"Breast cancer","volume":"397","author":"Loibl","year":"2021","journal-title":"Lancet"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"413","DOI":"10.21614\/chirurgia.112.4.413","article-title":"Hormone Therapy in Breast Cancer","volume":"112","author":"Carmocan","year":"2017","journal-title":"Chirurgia"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.soncn.2015.02.002","article-title":"Endocrine Therapy in Breast Cancer: The Neoadjuvant, Adjuvant, and Metastatic Approach","volume":"31","author":"Reinbolt","year":"2015","journal-title":"Semin. Oncol. Nurs."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1177\/1758834016687260","article-title":"A clinical guide to the management of genitourinary symptoms in breast cancer survivors on endocrine therapy","volume":"9","author":"Sousa","year":"2017","journal-title":"Ther. Adv. Med. Oncol."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Andrahennadi, S., Sami, A., Manna, M., Pauls, M., and Ahmed, S. (2021). Current Landscape of Targeted Therapy in Hormone Receptor-Positive and HER2-Negative Breast Cancer. Curr. Oncol., 28.","DOI":"10.3390\/curroncol28030168"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.breast.2020.10.015","article-title":"Tamoxifen related side effects and their impact on breast cancer incidence: A retrospective analysis of the randomised IBIS-I trial","volume":"54","author":"Hale","year":"2020","journal-title":"Breast"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3390\/jpm5020050","article-title":"Atrophic Vaginitis in Breast Cancer Survivors: A Difficult Survivorship Issue","volume":"5","author":"Lester","year":"2015","journal-title":"J. Pers. Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.ejmech.2017.11.057","article-title":"Potent aromatase inhibitors and molecular mechanism of inhibitory action","volume":"143","author":"Kang","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"609","DOI":"10.2174\/1389557517666171101100902","article-title":"Aromatase Inhibitors Evolution as Potential Class of Drugs in the Treatment of Postmenopausal Breast Cancer Women","volume":"18","author":"Avvaru","year":"2018","journal-title":"Mini-Rev. Med. Chem."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/GME.0b013e31829e41df","article-title":"Aromatase inhibitors affect vaginal proliferation and steroid hormone receptors","volume":"21","author":"Kallak","year":"2014","journal-title":"Menopause"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.1743-6109.2010.02034.x","article-title":"Sexual Function after Breast Cancer","volume":"8","author":"Panjari","year":"2011","journal-title":"J. Sex. Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s10549-007-9548-1","article-title":"Recognition and management of treatment-related side effects for breast cancer patients receiving adjuvant endocrine therapy","volume":"107","author":"Cella","year":"2008","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1097\/GME.0b013e31826560da","article-title":"Sexual dysfunction in women on adjuvant endocrine therapy after breast cancer","volume":"20","author":"Baumgart","year":"2013","journal-title":"Menopause"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1097\/GRF.0000000000000479","article-title":"Breast Cancer and the Obstetrician-Gynecologist: A Focus on Screening, Risk Assessment and Treatment of Survivors With Genitourinary Syndrome of Menopause","volume":"62","author":"Jasra","year":"2019","journal-title":"Clin. Obstet. Gynecol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1080\/09513590.2020.1813273","article-title":"The European Vulvovaginal Epidemiological Survey (EVES). Impact of history of breast cancer on prevalence, symptoms, sexual function and quality of life related to vulvovaginal atrophy","volume":"37","author":"Nappi","year":"2021","journal-title":"Gynecol. Endocrinol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s10549-021-06117-7","article-title":"Who is managing menopausal symptoms, sexual problems, mood and sleep disturbance after breast cancer and is it working? Findings from a large community-based survey of breast cancer survivors","volume":"187","author":"Peate","year":"2021","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Sbitti, Y., Kadiri, H., Essaidi, I., Fadoukhair, Z., Kharmoun, S., Slimani, K., Ismaili, N., Ichou, M., and Errihani, H. (2011). Breast cancer treatment and sexual dysfunction: Moroccan women\u2019s perception. BMC Womens Health, 11.","DOI":"10.1186\/1472-6874-11-29"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s10549-017-4305-6","article-title":"Sexual Health Needs and Educational Intervention Preferences for Women with Cancer","volume":"165","author":"Stabile","year":"2017","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1097\/GME.0000000000000926","article-title":"Missing documentation in breast cancer survivors: Genitourinary syndrome of menopause","volume":"24","author":"Cook","year":"2017","journal-title":"Menopause"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3816\/CBC.2009.n.020","article-title":"Prevalence and severity of urogenital symptoms in postmenopausal women receiving endocrine therapy for breast cancer","volume":"9","author":"Chin","year":"2009","journal-title":"Clin. Breast Cancer"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/01.GME.0000117061.40493.AB","article-title":"Association of breast cancer and its therapy with menopause-related symptoms","volume":"11","author":"Crandall","year":"2004","journal-title":"Menopause"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0378-5122(03)00087-2","article-title":"Menopause after breast cancer: A survey on breast cancer survivors","volume":"45","author":"Biglia","year":"2003","journal-title":"Maturitas"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"26.e1","DOI":"10.1016\/j.ajog.2010.08.035","article-title":"Urogenital disorders in women with adjuvant endocrine therapy after early breast cancer","volume":"204","author":"Baumgart","year":"2011","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"American College of Obstetricians and Gynecologists\u2019 Committee on Clinical Consensus\u2014Gynecology (2021). Treatment of Urogenital Symptoms in Individuals with a History of Estrogen-dependent Breast Cancer: Clinical Consensus. Obstet. Gynecol., 138, 950\u2013960.","DOI":"10.1097\/AOG.0000000000004601"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.clbc.2017.05.008","article-title":"Vaginal Atrophy in Breast Cancer Survivors: Attitude and Approaches Among Oncologists","volume":"17","author":"Biglia","year":"2017","journal-title":"Clin. Breast Cancer"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s11934-018-0831-y","article-title":"Laser Therapy for Genitourinary Syndrome of Menopause","volume":"19","author":"Rabley","year":"2018","journal-title":"Curr. Urol. Rep."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1097\/GCO.0000000000000230","article-title":"The use of pulsed CO2 lasers for the treatment of vulvovaginal atrophy","volume":"27","author":"Stefano","year":"2015","journal-title":"Curr. Opin. Obstet. Gynecol."},{"key":"ref_65","first-page":"1576359","article-title":"Laser Therapy in the Treatment of Female Urinary Incontinence and Genitourinary Syndrome of Menopause: An Update","volume":"2019","year":"2019","journal-title":"BioMed Res. Int."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1097\/GME.0000000000000401","article-title":"Histological study on the effects of microablative fractional CO2 laser on atrophic vaginal tissue: An ex vivo study","volume":"22","author":"Salvatore","year":"2015","journal-title":"Menopause"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s10103-014-1677-2","article-title":"Microscopic and ultrastructural modifications of postmenopausal atrophic vaginal mucosa after fractional carbon dioxide laser treatment","volume":"30","author":"Zerbinati","year":"2015","journal-title":"Lasers Med. Sci."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1007\/s10517-017-3650-0","article-title":"Structural Reorganization of the Vaginal Mucosa in Stress Urinary Incontinence under Conditions of Er:YAG Laser Treatment","volume":"162","author":"Lapii","year":"2017","journal-title":"Bull. Exp. Biol. Med."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/59\/1\/132\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:05:02Z","timestamp":1760119502000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/59\/1\/132"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,9]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1]]}},"alternative-id":["medicina59010132"],"URL":"https:\/\/doi.org\/10.3390\/medicina59010132","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,9]]}}}